Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-06-19

Clinical Trial Update: A Pharmacokinetic Study to Evaluate TREXIMET in Adolescents With Migraine and Healthy Subjects Administered at Three Doses. [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetic study evaluating TREXIMET (sumatriptan/acetaminophen) in adolescents with migraine and in healthy subjects at three dose levels; the stu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TREXIMET (sumatriptan succinate and naproxen sodium)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Migraine Disorders | Phase 1 | Status: COMPLETED